Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Beltran Pedro had 1,047 Bridgebio Oncology Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Beltran Pedro (Director, President and CEO) had 1,047 Bridgebio Oncology Therapeutics, Inc. shares withheld for tax at US$7.80 for US$8,167, leaving 44,576 shares. Filed Jul 6, 2026 (Form 4).
- Withheld for tax
- 1,047 shares
- Price
- US$7.80
- Value
- US$8,167
- Holding after
- 44,576 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Shares withheld for tax | 1,047 | US$7.80 | 44,576 | Direct |
Source
Related
- Bridgebio Oncology Therapeutics, Inc.
- Beltran Pedro
- Bridgebio Oncology Therapeutics, Inc. shareholders
- Form 4 · Beltran Pedro · Oct 5, 2026
- Form 4 · Beltran Pedro · May 5, 2026
- Form 4 · Ben Yong · Oct 5, 2026
- Form 4 · Elmelech Idan · Oct 5, 2026
- Form 4 · Cobo Marc · Oct 5, 2026
- Form 4 · Cobo Marc · Sep 14, 2026
- Form 4 · Cobo Marc · Jul 6, 2026